Now I have sufficient calibration context. Let me produce the final review.

## Summary

The paper proposes an end-to-end multi-view DR grading framework that generates lesion-like cues (GALP) from the model's own intermediate representations via class activation maps and auxiliary classifiers, then fuses cross-view information through a gated MoE module (LGRF). The method is evaluated on two datasets (MFIDDR, DRTiD) and achieves competitive results against methods requiring external annotations, while maintaining end-to-end training.

## Strengths

1. **Well-motivated problem and clean framing.** The paper articulates a genuine practical tension: externally informed methods (using lesion masks, vessel maps, etc.) perform better but require costly annotations and break end-to-end training. Figure 1 clearly contrasts the two paradigms, and the goal of generating lesion-like cues from the model's own representations is a reasonable strategy.

2. **Competitive quantitative results on two benchmarks with clean ablations.** On MFIDDR (Table 1), Ours (w/o lesion) at 83.9% accuracy surpasses all end-to-end baselines and several externally informed methods. On DRTiD (Table 3), it achieves the best overall accuracy (76.0%). The ablation study (Table 4) shows consistent degradation when removing GALP, experts, or LGRF (0.7–1.6% accuracy drops), providing reasonable evidence that each component contributes. Hyperparameter sweeps in Figure 3 are informative.

3. **Technically sound architectural design.** The GALP module's use of stage-wise auxiliary classifiers with CAM-based evidence maps to select grade-relevant regions is a sensible way to generate proposal-like cues without external supervision. The LGRF's use of cross-view-gated MoE with Top-K-weighted attention is a well-motivated design for selective fusion.

## Weaknesses

### Major

1. **Backbone architecture is not controlled across comparisons, weakening the headline claim.** The proposed method uses Swin-B, while many compared baselines (MVCNN_R: ResNet50, MVCNN_V: VGG19, and likely others such as MVCINN, Binocular Network, DeepDR) use older CNN backbones. Since Swin-B is substantially stronger than ResNet50/VGG19 on standard vision tasks, a non-trivial portion of the reported gains (e.g., 83.9% vs. MVCINN's 80.1%) may stem from the backbone rather than the proposed GALP/LGRF modules. The ablation (Table 4) does show that the modules contribute on top of Swin-B, but the gap to several baselines (2.6–3.8%) is larger than the ablation range (0.7–1.6%), leaving the independent contribution of the proposed mechanism unclear. The paper should either re-implement key baselines with a shared backbone, ablate on a weaker backbone (e.g., ResNet50), or at minimum discuss this confound explicitly.

### Minor

2. **No qualitative evidence that GALP proposals correspond to lesions.** The paper's central narrative is that GALP generates "lesion proposals" that act as surrogates for external annotations, yet it provides zero visualizations of GEMs or Top-K regions overlaid on fundus images. The MFIDDR dataset provides lesion segmentation masks that could be used for such validation. Without this, it remains possible that the proposals capture grade-discriminative regions other than lesions (e.g., image-level shortcuts), and the performance gains stem from the auxiliary classifiers providing stronger gradient signals at intermediate layers rather than from "lesion-aware" cues.

3. **Overstated "SOTA" language for the w/o-lesion variant.** On MFIDDR (Table 1), Ours (w/o lesion) at 83.9% is below WGLIN (with lesion, 84.2%) and SMVDR-M (with lesion, 84.0%). On DRTiD, the margin over CrossFIT is only 0.4% accuracy with no confidence intervals reported. The language should be calibrated to "competitive with externally informed methods" rather than "SOTA" for the annotation-free variant.

4. **No confidence intervals or statistical significance tests reported.** Given that several margins are small (0.4% on DRTiD, 0.3% vs WGLIN on specificity), readers cannot assess whether differences are meaningful.

5. **No computational cost comparison.** The method introduces MoE with 6 experts, auxiliary classifiers at 3 stages, cross-view attention, and tokenization/reshape operations. A comparison of FLOPs, parameters, or inference time against simpler baselines would help assess practical deployment potential.

### Trivial

6. **Missing "plain backbone" lower bound in ablation.** The "w/o LGRF" baseline still uses GALP proposals (concatenated), and "w/o GALP" still uses LGRF (with all tokens). A baseline that removes both and uses a simple multi-view classification head would establish the lower bound of the backbone alone.

## Nice-to-Haves

- Visualizing GEMs overlaid on fundus images alongside real lesion annotations (available in MFIDDR) to validate the "lesion proposal" narrative.
- Re-implementing 1–2 key baselines (e.g., MVCINN, CVSA) with the same Swin-B backbone to control for architecture.
- Reporting confidence intervals or statistical tests (e.g., McNemar's test) for the main comparisons.
- Ablating on a weaker backbone to demonstrate that GALP/LGRF provide gains beyond what a strong backbone alone would give.

## Removed Points

- **Criticism about "Spe" column missing for some methods in Table 1:** Re-reading the paper shows all methods have values for all columns. The critic may have misread the formatting.
- **Notation criticism of Eq. 3 (superscript `(s_n)`):** Minor and does not affect understanding or reproducibility.
- **Load-balancing loss formulation criticism:** The paper cites related work (Xie et al., 2025) and uses a standard variant; this is a minor presentational preference.
- **Cross-view fusion restricted to adjacent views:** The paper explicitly motivates this choice ("suppress background interference"); it is a reasonable design decision within scope.
- **Fixed retention ratio α across stages:** The hyperparameter analysis (Fig 3a) validates 50% globally; a stage-adaptive scheme is a potential extension, not a flaw.
- **ReLU discarding negative evidence in GEMs:** CAMs conventionally use ReLU to focus on positive evidence; this is standard practice.

## Novel Insights

None beyond the paper's own contributions. The key methodological observation from the harsh critic (backbone architecture confound) is valid but is a known limitation of comparing against published results; the paper's ablation study partially mitigates it by controlling for backbone internally.

## Suggestions

1. **Control for backbone architecture** in the external comparisons. Re-implement at least 2–3 key baselines (e.g., MVCINN, CVSA) with Swin-B, or ablate GALP/LGRF on a weaker backbone like ResNet50 to show that gains persist independent of backbone strength.
2. **Add qualitative validation of GALP proposals.** Show GEMs and Top-K selected regions overlaid on fundus images alongside actual lesion annotations from MFIDDR.
3. **Add confidence intervals or statistical tests** to the main comparison tables.
4. **Calibrate the language** around "SOTA" for the w/o-lesion variant — "competitive with externally informed methods" is more precise.
5. **Report FLOPs, parameter counts, and inference time** for the proposed method vs. baselines.

## Score and Decision

**Calibration anchors used:**

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| Eye Fairness (Lv9KZ5qCSG) | 5.50 | Narrowing | Ophthalmic dataset+method paper, rejected. Reviewed paper has stronger technical novelty but a more significant evaluation confound. |
| FairTune (ArpwmicoYW) | 6.00 | Narrowing | Medical imaging fairness method, accepted. Reviewed paper has more significant evaluation weakness (backbone confound) than FairTune's gaps (missing baselines/metrics). |
| MGDC-UNet (Naiy1jf8UA) | 6.00 | Round 2 | Medical image segmentation method, rejected for limited novelty. Reviewed paper has clearer novelty. |
| MONICA (qtqvuBmhxU) | 5.75 | Round 2 | Medical image benchmark paper, rejected for analysis depth. Reviewed paper has better analysis but a more significant evaluation weakness. |

**Round 1 bracket:** [4.5, 5.5]. After narrowing against the above anchors, the paper sits at the upper end of this range due to its clear technical contribution and clean ablations, but the backbone confound and lack of qualitative validation prevent it from reaching the 6+ range of accepted papers with similar scope.

The paper makes a genuine technical contribution (GALP + LGRF), and the ablation study provides reasonable evidence that these modules contribute beyond the backbone choice. However, the confidence in the paper's central claim (that self-generated lesion proposals can match externally informed methods) is undermined by the uncontrolled backbone across external comparisons. Combined with the lack of qualitative validation of the core mechanism and overstated language, the paper requires revision before acceptance.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>